Most Recent Posts

NVCA Letter to House EC Committee on FDA Reauthorization

04/25/2024
READ MORE

NVCA Comments to HHS on RFI Investment

04/25/2024
READ MORE

NVCA Comments to CMS on MCIT

04/25/2024
READ MORE

Summary of Changes to Rx Drug Pricing Reforms

04/25/2024
READ MORE

NVCA Letter to CMMS on TCET

04/25/2024
READ MORE